发布求助
文献互助 智能选刊 最新文献

Cell & gene therapy insights最新文献

筛选
英文 中文
Technical and regulatory opportunities and challenges for cell and gene therapies in low earth orbit: a status report. 近地轨道细胞和基因疗法的技术和监管机遇与挑战：现状报告。
Cell & gene therapy insights Pub Date : 2025-05-01 Epub Date: 2025-06-06 DOI: 10.18609/cgti.2025.167
Gary C du Moulin, Ian Sands, Mari Anne Snow, Yupeng Chen
{"title":"Technical and regulatory opportunities and challenges for cell and gene therapies in low earth orbit: a status report.","authors":"Gary C du Moulin, Ian Sands, Mari Anne Snow, Yupeng Chen","doi":"10.18609/cgti.2025.167","DOIUrl":"10.18609/cgti.2025.167","url":null,"abstract":"<p><p>The unique advantages exhibited by microgravity in enhancing the biological and chemical interactions for cells and tissues have come into greater focus following a quarter century of biological investigation aboard the International Space Station (ISS) in low earth orbit (LEO). One of its primary biomedical research purposes has been to investigate and mitigate the health risks faced by astronauts during prolonged spaceflight. However, as this status report describes, the hundreds of experiments aboard the ISS have also produced a vast quantity of knowledge opening up new possibilities for improving therapeutic modalities for the unmet medical needs of patients on earth. Among its many functions and capabilities, the ISS has been a preeminent biomedical research laboratory for biotechnology and drug development. Public-private partnerships have created the necessary collaborations and supplied the resources to conduct sophisticated biomedical experiments which have led to the improvement in the applications of stem cell biology, gene therapies, tissue engineering, and regenerative medicine. Technological advancements have also resulted in 3D bio printing of soft tissues such as blood vessels and micro physiological systems (Tissue on a Chip) using cells organized in a predetermined architecture. Nanomaterials assembled in microgravity formed with increased homogeneity and bioactivity can function as delivery platforms for cancer therapeutics or may be shaped into extracellular matrix supporting tissue regeneration therapies. Given these exciting innovations, and with the expectation that a robust regulatory framework will emerge, sustainable biomanufacturing in LEO is poised to unlock a transformative economic potential and accelerate the development of advanced next-generation therapeutics.</p>","PeriodicalId":72538,"journal":{"name":"Cell & gene therapy insights","volume":"11 4","pages":"545-577"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13322326/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148371081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Residual DNA testing: Homebrew vs off-the-shelf solutions: INFOGRAPHIC 残留DNA测试:自制与现成的解决方案:信息图
Cell & gene therapy insights Pub Date : 2023-08-04 DOI: 10.18609/cgti.2023.128
{"title":"Residual DNA testing: Homebrew vs off-the-shelf solutions: INFOGRAPHIC","authors":"","doi":"10.18609/cgti.2023.128","DOIUrl":"https://doi.org/10.18609/cgti.2023.128","url":null,"abstract":"","PeriodicalId":72538,"journal":{"name":"Cell & gene therapy insights","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136162756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Future-proof your AAV process with a complete producer cell line 为您的AAV工艺提供一个完整的生产细胞系
Cell & gene therapy insights Pub Date : 2023-08-04 DOI: 10.18609/cgti.2023.106
Dovile Gruzdyte
{"title":"Future-proof your AAV process with a complete producer cell line","authors":"Dovile Gruzdyte","doi":"10.18609/cgti.2023.106","DOIUrl":"https://doi.org/10.18609/cgti.2023.106","url":null,"abstract":"","PeriodicalId":72538,"journal":{"name":"Cell & gene therapy insights","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136162759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cell and gene therapy commercial off-the-shelf software components 细胞和基因治疗商业现成的软件组件
Cell & gene therapy insights Pub Date : 2023-08-04 DOI: 10.18609/cgti.2023.125
Parris Farr
{"title":"Cell and gene therapy commercial off-the-shelf software components","authors":"Parris Farr","doi":"10.18609/cgti.2023.125","DOIUrl":"https://doi.org/10.18609/cgti.2023.125","url":null,"abstract":"","PeriodicalId":72538,"journal":{"name":"Cell & gene therapy insights","volume":"218 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136162761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gene delivery platform evolution part 2: non-viral—Foreword 基因传递平台进化第2部分:非病毒前言
Cell & gene therapy insights Pub Date : 2023-08-04 DOI: 10.18609/cgti.2023.111
Lynn Zechiedrich
{"title":"Gene delivery platform evolution part 2: non-viral—Foreword","authors":"Lynn Zechiedrich","doi":"10.18609/cgti.2023.111","DOIUrl":"https://doi.org/10.18609/cgti.2023.111","url":null,"abstract":"","PeriodicalId":72538,"journal":{"name":"Cell & gene therapy insights","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136162764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navigating evolving regulatory CMC guidance in the AAV gene therapy field 在AAV基因治疗领域导航不断发展的监管CMC指导
Cell & gene therapy insights Pub Date : 2023-08-04 DOI: 10.18609/cgti.2023.131
Michael Brewer, Alexis Cockroft, Christina Fuentes, Christine Le Bec, Yan Zhi
{"title":"Navigating evolving regulatory CMC guidance in the AAV gene therapy field","authors":"Michael Brewer, Alexis Cockroft, Christina Fuentes, Christine Le Bec, Yan Zhi","doi":"10.18609/cgti.2023.131","DOIUrl":"https://doi.org/10.18609/cgti.2023.131","url":null,"abstract":"","PeriodicalId":72538,"journal":{"name":"Cell & gene therapy insights","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136162749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing universal AAV immuno-gene therapy for oncology 发展通用的肿瘤AAV免疫基因治疗
Cell & gene therapy insights Pub Date : 2023-08-04 DOI: 10.18609/cgti.2023.126
Nicole Paulk
{"title":"Developing universal AAV immuno-gene therapy for oncology","authors":"Nicole Paulk","doi":"10.18609/cgti.2023.126","DOIUrl":"https://doi.org/10.18609/cgti.2023.126","url":null,"abstract":"","PeriodicalId":72538,"journal":{"name":"Cell & gene therapy insights","volume":"110 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136162755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does synthetic biology hold the key to unlocking solid tumors for cell and gene therapy? 合成生物学是开启实体瘤细胞和基因治疗的关键吗?
Cell & gene therapy insights Pub Date : 2023-08-04 DOI: 10.18609/cgti.2023.120
Ming-Ru Wu
{"title":"Does synthetic biology hold the key to unlocking solid tumors for cell and gene therapy?","authors":"Ming-Ru Wu","doi":"10.18609/cgti.2023.120","DOIUrl":"https://doi.org/10.18609/cgti.2023.120","url":null,"abstract":"","PeriodicalId":72538,"journal":{"name":"Cell & gene therapy insights","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136162763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring current shortfalls and potential improvements for non-viral gene delivery in cystic fibrosis 探索目前囊性纤维化非病毒基因传递的不足和潜在的改进
Cell & gene therapy insights Pub Date : 2023-08-04 DOI: 10.18609/cgti.2023.112
Uta Griesenbach
{"title":"Exploring current shortfalls and potential improvements for non-viral gene delivery in cystic fibrosis","authors":"Uta Griesenbach","doi":"10.18609/cgti.2023.112","DOIUrl":"https://doi.org/10.18609/cgti.2023.112","url":null,"abstract":"","PeriodicalId":72538,"journal":{"name":"Cell & gene therapy insights","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136162765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reducing risk for cell therapy manufacturing with a battle-tested electroporation platform 通过久经考验的电穿孔平台降低细胞治疗制造的风险
Cell & gene therapy insights Pub Date : 2023-08-04 DOI: 10.18609/cgti.2023.100
Andrew Mancini
{"title":"Reducing risk for cell therapy manufacturing with a battle-tested electroporation platform","authors":"Andrew Mancini","doi":"10.18609/cgti.2023.100","DOIUrl":"https://doi.org/10.18609/cgti.2023.100","url":null,"abstract":"","PeriodicalId":72538,"journal":{"name":"Cell & gene therapy insights","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136162766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书